CGAP
Transform Sequencing Data
into Actionable Genetic Insights
Transform Sequencing Data into Actionable Genetic Insights
Transform Sequencing Data into Actionable Genetic Insights
The Computational Genome Analysis Platform (CGAP) is an intuitive, open-source analysis tool designed to support complex research & clinical genomics workflows.
The Computational Genome Analysis Platform (CGAP) is an intuitive, open-source analysis tool designed to support complex research & clinical genomics workflows.
The Computational Genome Analysis Platform (CGAP) is an intuitive, open-source analysis tool designed to support complex research & clinical genomics workflows.
A unified workflow for clinical & research use-cases
A unified workflow for clinical & research use-cases
A unified workflow for clinical & research
use-cases
We are implementing powerful variant discovery & diagnostic tools for individual samples
and cohorts with clinical accuracy and reporting capabilities in one platform.
We are implementing powerful variant discovery & diagnostic tools for individual samples
and cohorts with clinical accuracy and reporting capabilities in one platform.
We are implementing powerful variant discovery & diagnostic tools for individual samples and cohorts with clinical accuracy and reporting capabilities in one platform.
GENOMIC
MEDICINE
GENOMIC
MEDICINE
Interactive Family Collection and Phenotyping
ACMG Guideline-Based Intepretation & Reporting
CLIA-Compatible Workflow
Interactive Family Collection & Phenotyping
ACMG Guideline-Based Intepretation & Reporting
CLIA-Compatible Workflow
Interactive Family Collection & Phenotyping
ACMG Guideline-Based Intepretation & Reporting
CLIA-Compatible Workflow
GENE DISCOVERY
RESEARCH
GENE DISCOVERY
RESEARCH
Robust Knowledgebase of Genomic Variants
Flexible Filtering and Interpretation Tools
Easy Data-Sharing and Collaboration
Robust Knowledgebase of Genomic Variants
Flexible Filtering and Interpretation Tools
Easy Data-Sharing and Collaboration
How does CGAP Work?
How does CGAP Work?
How does
CGAP Work?
CGAP is a complete End-to-End Solution for Case & Cohort Analyses
CGAP is a complete End-to-End Solution for Case & Cohort Analyses
CGAP is Empowering Innovative Research & Clinical Care Collaborations
CGAP is Empowering Innovative Research & Clinical Care Collaborations
CGAP is Empowering Innovative Research & Clinical Care Collaborations
Undiagnosed Disease Network (UDN)
The UDN utilized CGAP’s customized rare disease variant callers to analyze thousands of whole genome samples and facilitate discovery across the UDN Cohort.
Multiple System Atrophy (MSA) Coalition
The MSA Coalition leverages CGAP’s case and cohort analysis workflows to uncover the genetic causes of MSA.
Undiagnosed Disease
Network (UDN)
The UDN utilized CGAP’s customized rare disease variant callers to analyze thousands of whole genome samples.
Multiple System Atrophy
(MSA) Coalition
The MSA Coalition leverages CGAP’s case and cohort analysis workflows to uncover the genetic causes of MSA.
Multiple System Atrophy
(MSA) Coalition
The MSA Coalition leverages CGAP’s case and cohort analysis workflows to uncover the genetic causes of MSA.
Brigham Genomic
Medicine (BGM)
BGM is identifying novel gene-disease associations in patients and families with unsolved rare genetic diseases.
Brigham Genomic
Medicine (BGM)
BGM is identifying novel gene-disease associations in patients and families with unsolved rare genetic diseases.
People Powered
Medicine (PPM)
PPM used CGAP to identify the genetic variants associated with exceptional response to cancer treatments.
People Powered
Medicine (PPM)
PPM used CGAP to identify the genetic variants associated with exceptional response to cancer treatments.
PROACTIVE Research
Clinical Study
PROACTIVE has successfully identified all actionable germ-line variants across clinical cancer cases.
PROACTIVE Research
Clinical Study
PROACTIVE has successfully identified all actionable germ-line variants across clinical cancer cases.
Undiagnosed Disease
Network (UDN)
The UDN utilized CGAP’s customized rare disease variant callers to analyze thousands of whole genome samples.
Undiagnosed Disease
Network (UDN)
The UDN utilized CGAP’s customized rare disease variant callers to analyze thousands of whole genome samples.
Multiple System Atrophy
(MSA) Coalition
The MSA Coalition leverages CGAP’s case and cohort analysis workflows to uncover the genetic causes of MSA.
Multiple System Atrophy
(MSA) Coalition
The MSA Coalition leverages CGAP’s case and cohort analysis workflows to uncover the genetic causes of MSA.
Brigham Genomic
Medicine (BGM)
BGM is identifying novel gene-disease associations in patients and families with unsolved rare genetic diseases.
Brigham Genomic
Medicine (BGM)
BGM is identifying novel gene-disease associations in patients and families with unsolved rare genetic diseases.
People Powered
Medicine (PPM)
PPM used CGAP to identify the genetic variants associated with exceptional response to cancer treatments.
People Powered
Medicine (PPM)
PPM used CGAP to identify the genetic variants associated with exceptional response to cancer treatments.
PROACTIVE Research
Clinical Study
PROACTIVE has successfully identified all actionable germ-line variants across clinical cancer cases.
PROACTIVE Research
Clinical Study
PROACTIVE has successfully identified all actionable germ-line variants across clinical cancer cases.
Built in Partnership with Experts in Informatics & Genomics
Built in Partnership with Experts in
Informatics & Genomics
Built in Partnership with Experts in Informatics & Genomics
Getting Started with CGAP
Getting Started with CGAP
Getting Started with CGAP
It's quick to learn and easy to use
It's quick to learn and easy to use
Easily Collaborate & Share Results
Collaborations within CGAP (Coming Soon)
Easily Collaborate & Share Results
Collaborations within CGAP (Coming Soon)
Easily Collaborate & Share Results
Collaborations within CGAP (Coming Soon)